Guest Editor(s)
-
- Prof. Beisha Tang
Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Website | E-mail
-
- Prof. Huaibin Cai
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Website | E-mail
Special Issue Introduction
The endocannabinoid system, comprising endocannabinoids, cannabinoid receptors, and synthetic and metabolizing enzymes, is crucial for many physiological and pathological processes in the nervous system. During the past decades, studies have indicated that the endocannabinoid system is involved in the nervous system development, synaptic plasticity, neuroinflammation, neurodegeneration, etc., and alterations in the endocannabinoid system are found in a variety of brain diseases, including Parkinson’s disease, Alzheimer disease, Huntington disease, stroke, epilepsy, multiple sclerosis, pain, and schizophrenia. However, the molecular mechanisms of endocannabinoid signaling in the brain still remain unclear, hence the need to fill this gap in order to develop clinically successful treatment strategies.
This special issue aims at expanding the current knowledge on the endocannabinoid system in the brain under physiological and pathological conditions. Research articles, reviews, and comments are all welcomed.
Keywords
The endocannabinoid system, endocannabinoids, brain, brain diseases
Submission Deadline
31 Mar 2023
Ageing and Neurodegenerative Diseases
